Calcium Gluconate
Sponsors
AstraZeneca AB, National Center for Research Resources (NCRR), Northwestern University, Alliance for Clinical Trials in Oncology, NCIC Clinical Trials Group
Conditions
ArthralgiaBlood Loss, PostoperativeBlood Loss, SurgicalBreast CancerChemotherapeutic Agent ToxicityColorectal CancerConotruncal Cardiac DefectsEsophageal Cancer
Early Phase 1
Phase 1
Endoscopic Assisted Calcium Electroporation in Esophageal Cancer
CompletedNCT04958044
Start: 2021-05-25End: 2022-06-13Updated: 2022-10-26
A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD9550 Monotherapy and Co-administration of AZD9550 and AZD6234 in Participants Living with Obesity and Overweight with or without Type 2 Diabetes Mellitus
Active, not recruitingCTIS2023-504215-32-00
Start: 2023-09-28Target: 101Updated: 2025-10-15
Phase 2
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
CompletedNCT00416715
Start: 2006-10-31End: 2010-05-31Updated: 2017-07-11
Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome
CompletedNCT02875587
Start: 2016-10-31End: 2018-12-31Updated: 2018-12-27
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RecruitingNCT05958342
Start: 2024-06-30End: 2028-03-01Target: 1050Updated: 2026-03-16
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or
Overweight with Comorbidity
Active, not recruitingCTIS2024-516176-15-00
Start: 2025-02-24Target: 40Updated: 2025-12-22
Calcium Administration in Life-saving Management During Massive Hemorrhage
Not yet recruitingNCT06820645
Start: 2025-05-01End: 2026-05-31Target: 81Updated: 2025-02-11
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
RecruitingNCT07217899
Start: 2025-10-20End: 2026-08-31Target: 140Updated: 2025-10-29
Phase 3
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
TerminatedNCT00058188
Start: 2003-03-31End: 2008-11-30Updated: 2020-12-08
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
CompletedNCT00316914
Start: 2006-01-31End: 2012-11-30Updated: 2016-08-11
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
CompletedNCT00354302
Start: 2006-04-24End: 2012-01-06Updated: 2020-04-02
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
TerminatedNCT00998738
Start: 2009-11-30End: 2013-01-31Updated: 2016-02-04
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
CompletedNCT01099449
Start: 2010-06-30End: 2013-03-31Updated: 2022-11-03
Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention
CompletedNCT03473613
Start: 2014-10-01End: 2017-04-15Updated: 2018-03-29
Empiric Calcium in Massive Transfusion
WithdrawnNCT05953376
Start: 2025-01-01End: 2026-12-01Updated: 2026-03-30
Phase 4
Unknown Phase
Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
CompletedNCT00004361
Start: 1995-07-31Target: 150Updated: 2005-06-24
Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin
CompletedNCT06333691
Start: 2022-10-01End: 2024-02-15Updated: 2025-01-07